Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).
No Thumbnail Available
Date
2008-05-14
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Hepatitis B virus infection continues to be a major global health problem with an estimated 350 million carriers. The response to available treatment modalities is not impressive. The advent of RNA Interference--a phenomenon of sequence-specific degradation of RNAs mediated by double-stranded RNA--holds promise as a potential therapy for chronic hepatitis B virus infection. Synthetic preparations of short RNA (21-23 bp long) can be used to mediate this process of gene silencing with a lower immune response. The duration of suppression can be further increased by using a vector delivery system. Small interfering RNA (siRNA) has several advantages over conventional therapy, which include fewer side-effects, a lower chance of developing escape mutants and non-requirement of viral replication for its action. A potent knockdown of the gene of interest with high sequence specificity makes RNA interference a powerful tool that has shown antiviral effect against hepatitis B virus. However, the 'off-target effect', i.e. suppression of genes other than the intended target, poor siRNA stability, inefficient cellular uptake, widespread biodistribution and non-specific effects need to be overcome. The problem of long-term toxicity of siRNA should be addressed and an ideal vector delivery system needs to be designed before it can be put to clinical use.
Description
36 references.
Keywords
Citation
Dwivedi M, Misra SP, Misra V, Waikhom RK, Bhatnagar M. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA). National Medical Journal of India. 2008 May-Jun; 21(3): 123-7